***Background.*** Thailand is a country with high incidence of tuberculosis. Despite low sensitivity in detection of *M.tuberculosis*, sputum smear remains the main diagnostic method. Recently, WHO endorsed Xpert MTB/RIF (Xpert) assay, real-time polymerase chain reaction technique to detect *M. tuberculosis*and rifampin resistance mutation. This study aimed to evaluate the diagnostic performance of Xpert assay among patients with clinically suspected pulmonary tuberculosis.

***Methods.*** A cross-sectional study was conducted at Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University between September 2012 and November 2013. We included patients who were aged ≥ 15 years and had clinically suspected pulmonary tuberculosis.

***Results.*** 99 specimens from 56 patients were included in the analysis; 29, 11, and 16 patients provided 1, 2, and 3 specimens, respectively. *M. tuberculosis*were detected from both Xpertassay and culture in 41 specimens, detected from Xpert assay but not culture in 5 specimens, detected from culture but not Xpert assay in 2 specimens, and neither detected from both methods in 51 specimens. Forty-three of 99 specimens (43.4%) had culture confirmed tuberculosis. Using sputum culture as a reference standard, the overall sensitivity (SEN), specificity (SPEC), positive predictive value (PPV), and negative predictive value (NPV) for Xpert assay were 95.4% (95% confidence interval \[CI\], 84.2%, 99.4%), 91.1% (95% CI, 80.4%,97.0%), 89.1% (95% CI, 76.4%, 96.4%), and 96.2% (95% CI, 87.0%, 99.5%), respectively. The overall SEN, SPEC, PPV, and NPV for sputum smear were 60.5% (95% CI, 44.4%, 75.0%), 98.2%, (95% CI, 90.4%, 100%), 96.3% (95% CI, 81.0%, 99.9%), and 76.4% (95% CI, 64.9%, 85.6%), respectively. Sensitivity of Xpert assay was 100% (95% CI, 86.7%, 100%) among smear positive specimens (n = 26) and 93.3% (95% CI, 68.0%, 99.8%) among smear negative specimens (n = 15). Subgroup analysis in HIV-infected patients (26 specimens) showed similar results. There were 3 specimens from 1 patient showed both INH and rifampin resistance, which Xpert failed to detect rifampin resistance in these specimens.

***Conclusion.*** This study demonstrated good sensitivity and specificity of Xpert assay in detecting *M. tuberculosis* from pulmonary specimens. This may help in diagnosis of patients who had smear-negative pulmonary TB, resulting in early detection and treatment initiation.
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